JPMorgan Chase & Co’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

JPMorgan Chase & Co’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-206,223	Closed	-$21M	–	6711
2023 Q2	$21M	Buy	206,223 +82,980	+67%	+$8.46M	﹤0.01%	1516
2023 Q1	$11.2M	Sell	123,243 -44,173	-26%	-$4.02M	﹤0.01%	1912
2022 Q4	$6.36M	Buy	167,416 +34,356	+26%	+$1.31M	﹤0.01%	2217
2022 Q3	$3.35M	Buy	133,060 +88,750	+200%	+$2.23M	﹤0.01%	2598
2022 Q2	$1.35M	Buy	44,310 +16,148	+57%	+$491K	﹤0.01%	3281
2022 Q1	$923K	Buy	28,162 +4,398	+19%	+$144K	﹤0.01%	3673
2021 Q4	$627K	Sell	23,764 -2,273	-9%	-$60K	﹤0.01%	3942
2021 Q3	$2.62M	Buy	26,037 +1,242	+5%	+$125K	﹤0.01%	3000
2021 Q2	$3.51M	Sell	24,795 -12,285	-33%	-$1.74M	﹤0.01%	2867
2021 Q1	$3.7M	Sell	37,080 -3,854	-9%	-$384K	﹤0.01%	2849
2020 Q4	$5.06M	Buy	40,934 +4,340	+12%	+$536K	﹤0.01%	2424
2020 Q3	$3.47M	Sell	36,594 -5,141	-12%	-$487K	﹤0.01%	2445
2020 Q2	$6.51M	Sell	41,735 -413	-1%	-$64.4K	﹤0.01%	1987
2020 Q1	$6.08M	Sell	42,148 -13,192	-24%	-$1.9M	﹤0.01%	1863
2019 Q4	$11.3M	Sell	55,340 -2,608	-5%	-$533K	﹤0.01%	1695
2019 Q3	$4.65M	Buy	57,948 +3,118	+6%	+$250K	﹤0.01%	2235
2019 Q2	$5.02M	Sell	54,830 -2,794	-5%	-$256K	﹤0.01%	2134
2019 Q1	$4.92M	Sell	57,624 -27,634	-32%	-$2.36M	﹤0.01%	2109
2018 Q4	$4.78M	Sell	85,258 -38,414	-31%	-$2.16M	﹤0.01%	2120
2018 Q3	$10.1M	Sell	123,672 -26,316	-18%	-$2.15M	﹤0.01%	1851
2018 Q2	$5.24M	Sell	149,988 -18,774	-11%	-$656K	﹤0.01%	2226
2018 Q1	$3.46M	Sell	168,762 -55,392	-25%	-$1.14M	﹤0.01%	2434
2017 Q4	$6.35M	Sell	224,154 -4,458	-2%	-$126K	﹤0.01%	2083
2017 Q3	$7.11M	Sell	228,612 -3,950	-2%	-$123K	﹤0.01%	1968
2017 Q2	$7.36M	Buy	232,562 +101,969	+78%	+$3.23M	﹤0.01%	1901
2017 Q1	$2.96M	Sell	130,593 -14,500	-10%	-$328K	﹤0.01%	2406
2016 Q4	$3.17M	Buy	145,093 +4,415	+3%	+$96.4K	﹤0.01%	2428
2016 Q3	$3.71M	Sell	140,678 -102,300	-42%	-$2.7M	﹤0.01%	2167
2016 Q2	$4.8M	Buy	+242,978	New	+$4.8M	﹤0.01%	2042